Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Bruchfeld

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2019
Rituximab in minimal change disease and focal segmental glomerulosclerosisAndreas Kronbichler, Philipp Gauckler, Annette Bruchfeld
Frontiers in Immunology|February 10, 2016
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseAnnette Bruchfeld, Mårten Wendt, Edmund J Miller
Transplantation|September 17, 2004
Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantationAnnette Bruchfeld, Henryk Wilczek, Carl-Gustaf Elinder
Hepatology (Baltimore, Md.)|January 22, 2005
High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis CKarin Lindahl, Lars Stahle, Annette Bruchfeld, et al.
Therapeutic Drug Monitoring|November 27, 2002
Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysisAnnette Bruchfeld, Karin Lindahl, Robert Schvarcz, et al.
Clinical Kidney Journal|June 23, 2017
B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritisSigrid Lundberg, Emelie Westergren, Jessica Smolander, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 15, 2024
Unlocking the Potential of Brewers' Spent Grain: A Sustainable Model to Use Beer for Better Outcome in Chronic Kidney DiseaseBabak Ghajavand, Carla Avesani, Peter Stenvinkel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiencyAnnette Bruchfeld, Karin Lindahl, Lars Ståhle, et al.
Kidney International Reports|April 6, 2021
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for NephrologistsSam Kant, Andreas Kronbichler, Antonio Salas, et al.
European Heart Journal. Case Reports|June 14, 2021
Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case reportSimon Sjuls, Ulf Jensen, Karin Littmann, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 4, 2019
Rituximab in minimal change disease and focal segmental glomerulosclerosisAndreas Kronbichler, Philipp Gauckler, Annette Bruchfeld
Frontiers in Immunology|February 10, 2016
Macrophage Migration Inhibitory Factor in Clinical Kidney DiseaseAnnette Bruchfeld, Mårten Wendt, Edmund J Miller
Transplantation|September 17, 2004
Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantationAnnette Bruchfeld, Henryk Wilczek, Carl-Gustaf Elinder
Hepatology (Baltimore, Md.)|January 22, 2005
High-dose ribavirin in combination with standard dose peginterferon for treatment of patients with chronic hepatitis CKarin Lindahl, Lars Stahle, Annette Bruchfeld, et al.
Therapeutic Drug Monitoring|November 27, 2002
Dosage of ribavirin in patients with hepatitis C should be based on renal function: a population pharmacokinetic analysisAnnette Bruchfeld, Karin Lindahl, Robert Schvarcz, et al.
Clinical Kidney Journal|June 23, 2017
B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritisSigrid Lundberg, Emelie Westergren, Jessica Smolander, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|April 15, 2024
Unlocking the Potential of Brewers' Spent Grain: A Sustainable Model to Use Beer for Better Outcome in Chronic Kidney DiseaseBabak Ghajavand, Carla Avesani, Peter Stenvinkel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2003
Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiencyAnnette Bruchfeld, Karin Lindahl, Lars Ståhle, et al.
Kidney International Reports|April 6, 2021
Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for NephrologistsSam Kant, Andreas Kronbichler, Antonio Salas, et al.
European Heart Journal. Case Reports|June 14, 2021
Effective cholesterol lowering after myocardial infarction in patients with nephrotic syndrome may require a multi-pharmacological approach: a case reportSimon Sjuls, Ulf Jensen, Karin Littmann, et al.
Pageof 16